SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Shandong Weigao Group Medical Polymer Company Limited Stock
Equities
1066
CNE100000171
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.34 HKD | +2.69% |
|
+10.10% | -29.83% |
| Sales 2024 * | 14.15B 1.95B 15.29B | Sales 2025 * | 15.97B 2.21B 17.26B | Capitalization | 22.59B 3.12B 24.41B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.2B 303M 2.37B | Net income 2025 * | 2.65B 365M 2.86B | EV / Sales 2024 * | 1.12 x |
| Net cash position 2024 * | 6.75B 932M 7.29B | Net cash position 2025 * | 7.73B 1.07B 8.35B | EV / Sales 2025 * | 0.93 x |
| P/E ratio 2024 * |
10.2
x | P/E ratio 2025 * |
8.47
x | Employees | 12,519 |
| Yield 2024 * |
3.1% | Yield 2025 * |
3.39% | Free-Float | 52.98% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | +2.69% | ||
| 1 week | +10.10% | ||
| Current month | +9.43% | ||
| 1 month | +9.43% | ||
| 3 months | -4.98% | ||
| 6 months | -23.82% | ||
| Current year | -29.83% |
1 week
4.93
5.39
1 month
4.305.39
Current year
4.307.70
1 year
4.3013.80
3 years
4.3020.65
5 years
4.3022.70
10 years
4.1122.70
| Managers | Title | Age | Since |
|---|---|---|---|
Rinan Cong
CEO | Chief Executive Officer | 43 | 03-07-31 |
Xue Feng Wu
DFI | Director of Finance/CFO | 46 | 01-06-30 |
Jing Long
CHM | Chairman | 50 | 05-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jing Long
CHM | Chairman | 50 | 05-06-30 |
Hong Meng
BRD | Director/Board Member | 58 | 22-09-27 |
Guo Hui Li
BRD | Director/Board Member | 52 | 22-06-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.66% | 2 M€ | -15.58% | - | |
| 1.04% | 16 M€ | -5.68% | ||
| 0.50% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 5.34 | +2.69% | 9,641,884 |
| 24-04-29 | 5.2 | +1.96% | 9,191,600 |
| 24-04-26 | 5.1 | +0.99% | 8,064,410 |
| 24-04-25 | 5.05 | +1.61% | 7,453,682 |
| 24-04-24 | 4.97 | -0.60% | 3,515,747 |
Delayed Quote Hong Kong S.E., April 30, 2024 at 04:08 am EDT
More quotes
Shandong Weigao Group Medical Polymer Co., Ltd. is principally engaged in the research and development, production and sale of single-use medical devices. The Company sells products under brand names of Jierui and Wego Ortho. The Company operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The Company is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.
Calendar
2024-06-02
- Final dividend
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
4.942
CNY
Average target price
7.037
CNY
Spread / Average Target
+42.39%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.83% | 3.12B | |
| +8.34% | 27.27B | |
| -15.97% | 2.53B | |
| +18.11% | 2.47B | |
| +3.70% | 2B | |
| -9.47% | 1.91B | |
| -2.22% | 1.48B | |
| +2.78% | 1.3B | |
| +18.92% | 1.18B | |
| +3.72% | 1.13B |
- Stock Market
- Equities
- 1066 Stock
